Safety and Efficacy of Transoral Robotic Thyroidectomy Versus Traditional Open Thyroidectomy for Thyroid Cancer

NCT ID: NCT06958601

Last Updated: 2025-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-01

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In general, the utilization of the transoral vestibular approach in robotic surgery demonstrates efficacy comparable to that of traditional open surgery in the treatment of thyroid cancer. This method not only reduces the length of hospitalization for patients but also ensures superior cosmetic outcomes in the cervical region, thus achieving truly scarless aesthetics. The feasibility of Transoral Vestibular Robotic Thyroidectomy (TOVRT) for tumors greater than 2 cm in diameter warrants further exploration in future studies; however, for tumors less than 2 cm in diameter, TOVRT emerges as a safe, reliable, and practical alternative, poised to establish itself as an innovative surgical modality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thyroid Cancers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

traditional open group

1\) General demographic information: including age, gender, ethnicity, etc. 2) Disease-related information: lesion size, lesion location, pathological type, parathyroid function (preoperative, first day postoperative, and one week postoperative), thyroid function (preoperative and one month postoperative), etc.3) Surgery-related information: occurrence of postoperative complications, total number of days of hospitalization following the operation, postoperative quality of life (dysphagia index, neck injury index), etc.

surgical procedure

Intervention Type OTHER

Effectiveness of different surgical modalities in the treatment of thyroid cancer

robotic group

1\) General demographic information: including age, gender, ethnicity, etc. 2) Disease-related information: lesion size, lesion location, pathological type, parathyroid function (preoperative, first day postoperative, and one week postoperative), thyroid function (preoperative and one month postoperative), etc.3) Surgery-related information: occurrence of postoperative complications, total number of days of hospitalization following the operation, postoperative quality of life (dysphagia index, neck injury index), etc.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

surgical procedure

Effectiveness of different surgical modalities in the treatment of thyroid cancer

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18- 65 years old, both male and female
* Postoperative pathology was papillary thyroid carcinoma
* Clinical data integrity

Exclusion Criteria

* Postoperative pathology was benign
* Clinical data are incomplete
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yan Xu

Role: CONTACT

15923100038

Fu Luo

Role: CONTACT

15121528940

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

No.357[2024]

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.